Delivery Order SPE2DP20D0002-SPE2DP24F5489
Award Date
6/13/24
Potential Completion Date
6/25/24
Potential Value
$318K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $158,804.73 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This vaccine supports military immunization programs. The contract has an ultimate completion date of August 27, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $635,218.92 firm fixed-price delivery order (SPE2DP24F7177) to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This order is part of a larger Indefinite Delivery Contract (SPE2DP20D0002) held by Teva to provide essential medications to federal agencies such as the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 A vaccine. The contract has a completion date of January 30, 2024 and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. has been awarded numerous prime federal contracts to supply critical pharmaceutical products to the Department of...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $158,804.73 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This delivery order is part of a larger contract vehicle, and Teva has received multiple prior delivery orders for this vaccine to support military immunization programs. Teva also holds several significant Indefinite...
This federal contract award, valued at $158,804.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a large, foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 27, 2024. Teva Pharmaceuticals USA, Inc. has a long history of supplying...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $635,218.92 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This vaccine supports military immunization programs. The contract has a completion date of July 30, 2024 and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. serves as a major supplier of critical drug products to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $635,218.92 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccines. This contract has a period of performance through May 21, 2024. Teva Pharmaceuticals USA, Inc. has provided Adenovirus Type 4 vaccines to the DLA Troop Support Medical through numerous previous delivery order awards, typically ranging...
This federal contract award, valued at $317,609.46, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc. for the delivery of the Adenovirus Type 4 vaccine. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that serves as a major supplier of critical drug products to various U.S. federal government agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $825,784.65, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a major supplier of critical medical products to federal agencies, including the Department of Veterans Affairs (VA), Department...